



References (continued):
- Sordi V, Malosio ML, Marchesi F et al. Bone marrow mesenchymal stem cells express a
restricted set of functionally active chemokine receptors capable of promoting migration to
pancreatic islets. Blood 2005;106:419–427.
- Le Blanc K, Tammik C, Rosendahl K et al. HLA expression and immunologic properties of
differentiated and undifferentiated mesenchymal stem cells. Exp Hematol 2003;31:890–
896.
- Baddoo M, Hill K, Wilkinson R et al. Characterization of mesenchymal stem cells isolated
from murine bone marrow by negative selection. J Cell Biochem 2003;89:1235–1249.
- Jones EA, Kinsey SE, English A et al. Isolation and characterization of bone marrow
multipotential mesenchymal progenitor cells. Arthritis Rheum 2002;46:3349–3360.
- Gindraux F, Selmani Z, Obert L et al. Human and rodent bone marrow mesenchymal stem
cells that express primitive stem cell markers can be directly enriched by using the CD49a
molecule. Cell Tissue Res 2007;327:471–483.
- Peister A, Mellad JA, Larson BL et al. Adult stem cells from bone marrow (MSCs) isolated
from different strains of inbred mice vary in surface epitopes, rates of proliferation, and
differentiation potential. Blood 2004;103:1662–1668.
- Gronthos S, Simmons PJ, Graves SE et al. Integrin-mediated interactions between human
bone marrow stromal precursor cells and the extracellular matrix. Bone 2001;28:174–181.
- Zvaifler NJ, Marinova-Mutafchieva L, Adams G et al. Mesenchymal precursor cells in the
blood of normal individuals. Arthritis Res 2000;2:477–488.
- Frid MG, Brunetti JA, Burke DL et al. Hypoxia-induced pulmonary vascular remodeling
requires recruitment of circulating mesenchymal precursors of a monocyte/macrophage
lineage. Am J Pathol 2006;168:659–669.
- in't Anker PS, Noort WA, Scherjon SA et al. Mesenchymal stem cells in human second-
trimester bone marrow, liver, lung, and spleen exhibit a similar immunophenotype but a
heterogeneous multilineage differentiation potential. Haematologica 2003;88:845–852.
- Le Blanc K, Ringden O. Immunobiology of human mesenchymal stem cells and future use
in hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2005;11:321–
334.
- Gotherstrom C, Ringden O, Tammik C et al. Immunologic properties of human fetal
mesenchymal stem cells. Am J Obstet Gynecol 2004;190:239–245.
- Hanada K, Dennis JE, Caplan AI. Stimulatory effects of basic fibroblast growth factor and
bone morphogenetic protein-2 on osteogenic differentiation of rat bone marrow-derived
mesenchymal stem cells. J Bone Miner Res 1997;12:1606–1614.
- Diefenderfer DL, Osyczka AM, Reilly GC et al. BMP responsiveness in human
mesenchymal stem cells. Connect Tissue Res 2003;44 (suppl 1):305–311.
- Knippenberg M, Helder MN, Zandieh DB et al. Osteogenesis versus chondrogenesis by
BMP-2 and BMP-7 in adipose stem cells. Biochem Biophys Res Commun 2006;342:902–
908.
- Wakitani S, Saito T, Caplan AI. Myogenic cells derived from rat bone marrow
mesenchymal stem cells exposed to 5-azacytidine. Muscle Nerve 1995;18:1417–1426.
- Woodbury D, Schwarz EJ, Prockop DJ et al. Adult rat and human bone marrow stromal cells
differentiate into neurons. J Neurosci Res 2000;61:364–370.
- Reyes M, Lund T, Lenvik T et al. Purification and ex vivo expansion of postnatal human
marrow mesodermal progenitor cells. Blood 2001;98:2615–2625.
- Mackay AM, Beck SC, Murphy JM et al. Chondrogenic differentiation of cultured human
mesenchymal stem cells from marrow. Tissue Eng 1998;4:415–428
- Kopen GC, Prockop DJ, Phinney DG. Marrow stromal cells migrate throughout forebrain
and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse
brains. Proc Natl Acad Sci U S A 1999;96:10711–10716.
- Kohyama J, Abe H, Shimazaki T et al. Brain from bone: Efficient "meta-differentiation" of
marrow stroma-derived mature osteoblasts to neurons with Noggin or a demethylating
agent. Differentiation 2001;68:235–244.\
- Hofstetter CP, Schwarz EJ, Hess D et al. Marrow stromal cells form guiding strands in the
injured spinal cord and promote recovery. Proc Natl Acad Sci U S A 2002;99:2199–2204.
Mesenchymal Stem Cells - Interest Group